Drug Trial Radar · NCT02390947
Safety and Efficacy Study of Famitinib in Patients With Advanced Colorectal Adenocarcinoma(FACT)
Last checked: Nov 20, 2026Latest source record: Dec 22, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
543
Actual
Start
Jan 2015
Primary completion
Feb 2019
Study completion Jul 2019
Sponsor
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Mar 18, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Famitinib is a tyrosin-inhibitor agent targeting at c-Kit, VEGFR2, PDGFR, VEGFR3, Flt1 and Flt3, whose anti-tumor and anti-angiogenesis effects have been validated in preclinical tests. In PhaseⅡb study, a significantly improved Progression Free Survival (PFS) was found in patients with advanced colorectal cancer treated with Famitinib compared to placebo. On the other hand, the toxicity of Famitinib was manageable in both PhaseⅠand Ⅱb studies. The purpose of this study is to determine whether Famitinib can improve Overall Survival (OS) compared with placebo in total 540 patients with advanced colorectal cancer who have failed in previously received at least two lines of standard chemotherapy.
Conditions
- Colorectal Cancer Metastatic
- Colorectal Cancer Recurrent
Interventions
FamitinibDrug
25 mg p.o. qd
PlaceboDrug
25 mg p.o. qd
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Survival(OS)Time frame: 3 years
Locations
44 sites in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
The Second Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
Beijing Cancer Hospital, Peking University
Beijing, Beijing Municipality, China
Beijing Chao-yang Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Chinese Academy of Medical Sciences Cancer Hospital
Beijing, Beijing Municipality, China
PLA Hospital 301
Beijing, Beijing Municipality, China
The Third Affiliated Hospital of The Third Military Medical University
Chongqing, Chongqing Municipality, China
Fujian Medical University Union Hospital
Fuzhou, Fujian, China
Cancer center, Sun Yet-sen University
Guangzhou, Guangdong, China
The First Affiliated Hospital of Guangzhou Medical University of Chinese Medicine
Guangzhou, Guangdong, China
Cancer Hospital of Guangxi Zhuang Autonomous Region
Nanning, Guangxi, China
Hospital of Guangxi Zhuang Autonomous Region
Nanning, Guangxi, China
Hainan General Hospital
Hainan, Hainan, China
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China
The first affiliated hospital of Xinxiang medical university
Xinxiang, Henan, China
Cancer Hospital of Henan Province
Zhengzhou, Henan, China
The First affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Wuhan General Hospital of Guangzhou Military
Wuhan, Hubei, China
Cancer Hospital of Hunan Province
Changsha, Hunan, China
The Third Xiangya Hospital of Cental South University
Changsha, Hunan, China
The First People's Hospital of Changzhou
Changzhou, Jiangsu, China
Cancer Hospital of Jiangsu Province
Nanjing, Jiangsu, China
The Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
The Affiliated Hospital of Xuzhou Medical Collage
Xuzhou, Jiangsu, China
Cancer Hospital of Jiangxi Province
Nanchang, Jiangxi, China
The Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Cancer Hospital of Jilin province
Changchun, Jilin, China
The First Affiliated Hospital of Jilin University
Changchun, Jilin, China
Cancer Hospital of Liaoning Province
Shenyang, Liaoning, China
Chinese Medical University First Hospital
Shenyang, Liaoning, China
Fudan University Cancer Hospital
Shanghai, Shanghai Municipality, China
Ruijin Hospital, Shanghai jiaotong University, School of Medicine
Shanghai, Shanghai Municipality, China
Shanghai General Hospital
Shanghai, Shanghai Municipality, China
Zhongshan Hospital of Fudan University
Shanghai, Shanghai Municipality, China
Cancer Hospital of Shanxi Province
Xian, Shanxi, China
Tangdu Hospital of The Fouth Military Medical University
Xian, Shanxi, China
Cancer Hospital of Tianjin City
Tianjin, Tianjin Municipality, China
Showing 40 of 44 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.